Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STAAR SURGICAL COSTAA · Entity 4851 | Sr. VP, Comm. Ops., NA, APAC | March 20, 2023 | March 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STAAR SURGICAL CO
Report date March 20, 2023 · Filed March 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,660 |
Reported balance
After 2023-03-20 transaction · row 1
1 source rowRow 1 · 2023-03-20 · Tax withholding · Disposed 797 · Balance 42,660 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2020 Filed Mar 24, 2020 20:13 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 14,374 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020917 · doc4.xml · derivative · entry 3 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,374 Underlying: Common Stock · 14,374 shares Expires 2030-03-19 F3 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:13 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 6,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020917 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,716 F1 · security: Award of 6913 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.